Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells

Environmental Toxicology and Pharmacology

Volumn 28, Issue 1, 2009, Pages 97-103

  Han, Ling Li ^a   Xie, Li Ping ^a   Li, Ling Hui ^a   Zhang, Xiao Wen ^a   Zhang, Rong Qing ^a   Wang, Hong Zhong ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; Honokiol; Reactive oxygen species (ROS)

Indexed keywords

HONOKIOL; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL SHAPE; CELL STRUCTURE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION;

EID: 67349230885     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2009.03.005     Document Type: Article

References (39)

1. Agostinis P. Bcl2 phosphorylation: a tie between cell survival, growth, and ROS. Blood 102 (2003) 3079
2. Ahn K.S., Sethi G., Shishodia S., Sung B., Arbiser J.L., and Aggarwal B.B. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappa B activation pathway. Molecular Cancer Research 4 (2006) 621-633
3. Amblard F., Delinsky D., Arbiser J.L., and Schinazi R.F. Honokiol and Magnolol: New potent antitumor compounds. Abstracts of Papers of the American Chemical Society (2006) 231-
4. Antonsson B., and Martinou J.C. The Bcl-2 protein family. Experimental Cell Research 256 (2000) 50-57
5. Bai X.H., Cerimele F., Ushio-Fukai M., Waqas M., Campbell P.M., Govindarajan B., Der C.J., Battle T., Frank D.A., Ye K.Q., et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. Journal of Biological Chemistry 278 (2003) 35501-35507
6. Battle T.E., Arbiser J., and Frank D.A. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106 (2005) 690-697
7. Berry W.L., Houchen C.W., and Anant S. P53-dependent and p53-independent mechanisms of apoptosis in human colorectal cancer cell lines following treatment with honokiol. Gastroenterology 134 (2008) A286
8. Bowie A., and O'Neill L.A.J. Oxidative stress and nuclear factor-kappa B activation-a reassessment of the evidence in the light of recent discoveries. Biochemical Pharmacology 59 (2000) 13-23
9. Cai R.L., Meng W., Lu H.Y., Lin W.Y., Jiang F., and Shen F.M. Segregation analysis of hepatocellular carcinoma in a moderately high-incidence area of East China. World Journal of Gastroenterology 9 (2003) 2428-2432
10. Chen F., Wang T., Wu Y., Gu Y., Xu X., Zheng S., and Hu X. Honokiol: a potent chemotherapy candidate for human coloretical cancinoma. World Journal of Gastroenterology 10 (2004) 3459-3463
11. Desagher S., and Martinou J.C. Mitochondria as the central control point of apoptosis. Trends in Cell Biology 10 (2000) 369-377
12. Hahm E.R., and Singh S.V. Honokiol causes G(0)-G(1) phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/ph osphorylation and inhibition of E2F1 transcriptional activity. Molecular Cancer Therapeutics 6 (2007) 2686-2695
13. Heussler V.T., Fernandez P.C., Machado J.J., Botteron C., and Dobbelaere D.A. N-acetylcysteine blocks apoptosis induced by N-a-tosyl-L-phenylalanine chloromethyl ketone in transformed T-cells. Cell Death and Differentiation 6 (1999) 342-350
14. Hibasami H., Achiwa Y., Katsuzaki H., Imai K., Yoshioka K., Nakanishi K., Ishii Y., Hasegawa M., and Komiya T. Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells. International Journal of Molecular Medicine 2 (1998) 671-673
15. Hirano T., Gotoh M., and Oka K. Natural flavonoids and lignans are potent cytostatic agents against human leukemic Hl-60 cells. Life Sciences 55 (1994) 1061-1069
16. Hirsch T., Marzo I., and Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Bioscience Reports 17 (1997) 67-76
17. Hochenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.J. Bcl-2 function in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
18. Hou Q., Cymbalyuk E., Hsu S.C., Xu M., and Hsu Y.T. Apoptosis modulatory activities of transiently expressed Bcl-2: roles in cytochrome c release and Bax regulation. Apoptosis 8 (2003) 617-629
19. Hu W., and Kavanagh J.J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncology 4 (2003) 721-729
20. Ishitsuka K., Hideshima T., Hamasaki M., Raje N., Kumar S., Hideshima H., Shiraishi N., Yasui H., Roccaro A.M., Richardson P., et al. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 106 (2005) 1794-1800
21. Johnson L.V., Walsh M.L., and Chen L.B. Localization of mitochondria in living cells with rhodamine 123. Proceedings of the National Academy of Sciences of the United States of America 77 (1980) 990-994
22. Jurgensmeier J.M., Xie Z.H., Deveraux Q., Ellerby L., Bredesen D., and Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 4997-5002
23. Karin M., Takahashi T., Kapahi P., Delhase M., Chen Y., Makris C., Rothwarf D., Baud V., Natoli G., Guido F., et al. Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors 15 (2001) 87-89
24. Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., Smith R.A.J., and Murphy M.P. Selective targeting of a redox-active ubiquinone to mitochondria within cells-antioxidant and antiapoptotic properties. Journal of Biological Chemistry 276 (2001) 4588-4596
25. Kroemer G., Zamzami N., and Susin S. Mitochondrial control of apoptosis. Immunology Today 18 (1997) 44-51
26. Li N.X., and Karin M. Is NF-kappa B the sensor of oxidative stress?. FASEB Journal 13 (1999) 1137-1143
27. Nagase H., Ikeda K., and Sakai Y. Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080 invasiveness in vitro. Planta Medica 67 (2001) 705-708
28. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
29. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature 387 (1997) 773-776
30. Shigemura K., Arbiser J.L., Sun S.Y., Zayzafoon M., Johnstone P.A.S., Fujisawa M., Gotoh A., Weksler B., Zhau H.E., and Chung L.W.K. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109 (2007) 1279-1289
31. Simon H.U., Haj-Yehia A., and Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5 (2000) 415-418
32. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. American Journal of Physiology-Lung Cellular and Molecular Physiology 279 (2000) L1005-L1028
33. Tse A.K.W., Wan C.K., Shen X.L., Yang M.S., and Fong W.F. Honokiol inhibits TNF-alpha-stimulated NF-kappa B activation and NF-kappa B-regulated gene expression through suppression of IKK activation. Biochemical Pharmacology 70 (2005) 1443-1457
34. van Loo G., Saelens X., van Gurp M., MacFarlane M., Martin S.J., and Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death and Differentiation 9 (2002) 1031-1042
35. Vaux D.L., and Korsmeyer S.J. Cell death in development. Cell 96 (1999) 245-254
36. Wang T., Chen F., Chen Z., Wu Y., Xu X., zheng S., and Hu X. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World Journal of Gastroenterology 10 (2004) 2205-2208
37. Wang X., Wang Y.Q., Geng Y.L., Li F.W., and Zheng C.C. Isolation and purification of honokiol and magnolol from cortex Magnoliae officinalis by high-speed counter-current chromatography. Journal of Chromatography A 1036 (2004) 171-175
38. Yang S.E., Hsieh M.T., Tsai T.H., and Hsu S.L. Down-modulation of Bcl-X-L, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochemical Pharmacology 63 (2002) 1641-1651
39. Ying M.D., Tu C.X., Ying H.Z., Hu Y.Z., He Q.J., and Yang B. MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway. Journal of Pharmacology and Experimental Therapeutics 325 (2008) 758-765